SCHEMBL9301358

SCHEMBL9301358

O=[N+]([O-])c1cccc(S(=O)(=O)Nc2nncs2)c1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.57
KDM1A O60341 2/20 0.56
AKT1 P31749 1/20 0.56
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
MMP1 P03956 1/20 0.55
MMP2 P08253 1/20 0.55
MMP9 P14780 1/20 0.55
MMP8 P22894 1/20 0.55
MMP13 P45452 1/20 0.55
FSCN1 Q16658 1/20 0.55
LMNA P02545 1/20 0.54
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
DDX3X O00571 1/20 0.53
TSHR P16473 1/20 0.52
KDM4E B2RXH2 1/20 0.52
MAPT P10636 1/20 0.52
EDNRA P25101 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2196395 0.85 AKT1 (0.67) ALDH1A1AKT1MEN1KMT2ATSHR
SCHEMBL9301664 0.80 ALDH1A1 (0.61) ALDH1A1KDM1ACA1CA2MMP1
SCHEMBL9301440 0.79 AKT1 (0.69) ALDH1A1AKT1CA1CA2MEN1
SCHEMBL11891722 0.79 AKT1 (0.57) KDM1AAKT1CA1CA2MEN1
SCHEMBL299526 0.77 AKT1 (0.71) AKT1CA1CA2MEN1KMT2A
SCHEMBL3154274 0.75 CA1 (0.61) AKT1CA1CA2MEN1KMT2A
SCHEMBL1094038 0.75 AKT1 (0.53) AKT1MEN1KMT2ATSHR
SCHEMBL13590904 0.74 CA2 (0.75) ALDH1A1CA1CA2MMP1MMP2
SCHEMBL4101284 0.74 PGR (0.78) ALDH1A1CA1CA2MMP1MMP2
SCHEMBL24477126 0.73 AKT1 (0.51) ALDH1A1AKT1MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5360802-A Antagonists of cholecystokinin and gastrin MERCK SHARPE & DOHME LTD. 1994-11-01 US disclosed
EP-0514133-A1 Benzodiazepine derivatives, compositions containing them and their use in therapy MERCK SHARP & DOHME LTD. (GB) 1992-11-19 EP disclosed